Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mueller Peter
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   311,837    

Indirect Shares

   25,571      
Direct Value   $68,249,240    

Indirect Value

   $12,120,654      
Total Shares   337,408      
Total Value   $80,369,894      


Vertex Pharmaceuticals Inc $68,027,058 Bioxcel Therapeutics Inc $222,182 Vertex Pharmaceuticals Inc $68,027,058 Bioxcel Therapeutics Inc $222,182
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, Global R&D, CSO 2014-06-16 143,517 2014-06-16 25,571    Premium*  
            Bioxcel Therapeutics Inc BTAI Director 2019-08-23 168,320 2018-12-04 0    Premium*  
* Premium Members only  

Records found :    141         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-07-16 4 AS $52.49 $343,060 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-08-15 4 AS $53.84 $351,846 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-09-17 4 AS $57.52 $373,880 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-10-15 4 AS $52.83 $344,015 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       •      –    2011-02-03 4 A $0.01 $145 D/D 14,501 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-04-11 4 AS $47.83 $1,921,020 D/D (40,000) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-04-15 4 AS $47.28 $118,716 D/D (2,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-04-25 4 AS $50.00 $625,000 D/D (12,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-05-16 4 AS $55.44 $142,554 D/D (2,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-06-15 4 AS $46.50 $116,698 D/D (2,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-07-15 4 AS $50.68 $126,700 D/D (2,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-08-29 4 AS $45.01 $427,595 D/D (9,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-09-15 4 AS $50.03 $476,848 D/D (9,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-09-20 4 AS $52.50 $1,312,500 D/D (25,000) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-04-15 4 OE $10.41 $26,025 D/D 2,500 136,235 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-05-16 4 OE $10.41 $26,025 D/D 2,500 136,235 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-06-15 4 OE $10.41 $26,025 D/D 2,500 136,235 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-07-15 4 OE $10.41 $26,025 D/D 2,500 136,235 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-06-15 4 OE $16.32 $106,080 D/D 6,500 138,816 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-07-16 4 OE $16.32 $106,080 D/D 6,500 138,816 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-08-15 4 OE $16.32 $106,080 D/D 6,500 138,816 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-09-17 4 OE $16.32 $106,080 D/D 6,500 138,816 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-10-15 4 OE $16.32 $106,080 D/D 6,500 138,816 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-12-12 4 AS $65.48 $189,892 D/D (2,900) 141,500 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-12-16 4 AS $64.40 $485,142 D/D (7,500) 141,500 0 -
  141  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us